CLDX — Celldex Therapeutics Inc. price, chart and key statistics

Price data

Price

$27.53

YTD price return

+1.36%

YTD total return

+1.36%

Next earnings

Nov 9, 2026

Market cap

2.2B2016-12 358.4M2026-10 2.2B+503.4% over the window

Enterprise value

1.4B

Shares outstanding

78.5M2016-06 6.7M2026-06 78.5M+1071.6% over the window

52W low

$22.10

52W high

$45.14

From 52W high

-39.01%

From 52W low

+24.57%

52W range

24%

Volume

Rel volume

0.52×

30D volume

1.9M

30D $ vol

62.7M

Fundamentals

Sales (ttm)

158K2016-06 5.5M2026-06 158K-97.1% over the window

Sales/share

$0.002016-06 $0.822026-06 $0.00-99.8% over the window

EPS (ttm)

-$3.862019-12 -$3.512026-06 -$3.86+10.0% over the window

FCF (ttm)

-242.1M2016-06 -113.3M2026-06 -242.1M+113.6% over the window

FCF/share

-$3.082016-06 -$16.912026-06 -$3.08-81.8% over the window

Book value/share

$9.102016-06 $35.022026-06 $9.10-74.0% over the window

Net margin

-190220.89%2016-06 -2383.6%2026-06 -190220.9%+7880.4% over the window

ROE

-42.06%2016-06 -55.9%2026-06 -42.1%-24.8% over the window

ROA

-38.42%2016-06 -48.4%2026-06 -38.4%-20.6% over the window

Current ratio

11.822016-06 11.442026-06 11.82+3.4% over the window

Growth (CAGR, ttm) · 10Y

Sales

-97.28%2025-06-30 → 2026-06-305.8M → 158K (-97.3% total)-63.51%2023-06-30 → 2026-06-303.3M → 158K (-95.1% total)-55.06%2021-06-30 → 2026-06-308.6M → 158K (-98.2% total)-29.90%2016-06-30 → 2026-06-305.5M → 158K (-97.1% total)

Shares

+18.27%2025-06-30 → 2026-06-3066.4M → 78.5M (+18.3% total)+18.44%2023-06-30 → 2026-06-3047.3M → 78.5M (+66.2% total)+11.06%2021-06-30 → 2026-06-3046.5M → 78.5M (+68.9% total)+27.91%2016-06-30 → 2026-06-306.7M → 78.5M (+1071.6% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-97.70%2025-06-30 → 2026-06-30$0.09 → $0.00 (-97.7% total)-69.19%2023-06-30 → 2026-06-30$0.07 → $0.00 (-97.1% total)-59.54%2021-06-30 → 2026-06-30$0.19 → $0.00 (-98.9% total)-45.19%2016-06-30 → 2026-06-30$0.82 → $0.00 (-99.8% total)

Book value/share

-7.81%2025-06-30 → 2026-06-30$9.87 → $9.10 (-7.8% total)+15.71%2023-06-30 → 2026-06-30$5.87 → $9.10 (+54.9% total)+18.34%2021-06-30 → 2026-06-30$3.92 → $9.10 (+132.0% total)-12.61%2016-06-30 → 2026-06-30$35.02 → $9.10 (-74.0% total)

Price

+3.69%2025-10-16 → 2026-10-16$26.55 → $27.53 (+3.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.92%2023-10-16 → 2026-10-16$26.78 → $27.53 (+2.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-9.82%2021-10-15 → 2026-10-16$46.18 → $27.53 (-40.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.09%2016-10-14 → 2026-10-16$51.60 → $27.53 (-46.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+3.69%2025-10-16 → 2026-10-16$26.55 → $27.53 (+3.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.92%2023-10-16 → 2026-10-16$26.78 → $27.53 (+2.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-9.82%2021-10-15 → 2026-10-16$46.18 → $27.53 (-40.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.09%2016-10-14 → 2026-10-16$51.60 → $27.53 (-46.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-7.1×2016-12 -2.782026-10 -7.20+158.8% over the window

Fwd P/E

-7.1×

P/S (ttm)Market cap ÷ TTM revenue.

13683.0×2016-12 53.482026-10 13688.00+25494.8% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.0×2016-12 1.652026-10 3.03+83.3% over the window

EV/Sales (ttm)

9156.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-11.20%2016-09 -30.4%2026-06 -8.3%-72.7% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 78.5M ÷ 66.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-18.27%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-18.27%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-18.27%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-323.8M) ÷ today's market cap ($2.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-14.98%2016-09 -3.0%2026-06 -11.1%+272.4% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-323.8M + TTM dividends $0) ÷ today's market cap ($2.2B). Same caveat as the cash buyback yield.

-14.98%2016-09 -3.0%2026-06 -11.1%+272.4% over the window

Vs own 10Y history

P/S

97th

P/B

56th